Features

Sort by: Newest first Oldest first A-Z Z-A

Everything you should know about the coronavirus outbreak

The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
Why we need to talk about sex and clinical trials Subscription

The under-representation of women in clinical trials is slowly being addressed, but we cannot move towards truly personalised healthcare unless we have an equal balance of the sexes in all new medicine trials.
Isolated, but not alone: how pharmacies are supporting older patients during COVID-19

Community pharmacy is providing a vital connection to support older and clinically vulnerable patients during lockdown in the UK.
Pharmacy — one of the driving forces behind the COVID-19 emergency hospitals

The temporary field hospitals set up across the UK to help the NHS cope during the COVID-19 pandemic have given hospital pharmacists a unique opportunity for valuable learning and teamwork.
Transcending boundaries: the role of pharmacists in gender identity services Subscription

There has been a surge in demand for gender identity services in the UK over the past five years. Although the current role of pharmacists is limited, their potential contribution within a multidisciplinary team supporting transgender patients is beginning to emerge.
Are pharmacy teams being protected against COVID-19?

When Public Health England published new guidance on the use of personal protective equipment during the COVID-19 pandemic on 2 April 2020, pharmacy’s representative bodies thought the battle was won.
The hunt for an effective treatment for COVID-19

As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.
Stopping the spread: ending the resurgence of gonorrhoea Subscription

Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.
Going against type: the new class of cancer therapies targeting mutations rather than tissues Subscription

‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
The true impact of the UK’s hormone replacement therapy shortages Subscription

More than 18 months of hormone replacement therapy product shortages have had a drastic impact on the lives of people who rely on them, but nobody seems to know why they are happening.